Scarica l'app Stockscreener
4.08
1.21%
-0.05
Dopo l'orario di chiusura:
4.08
Adc Therapeutics Sa Borsa (ADCT) Ultime notizie
Why institutional investors increase stakes in ADC Therapeutics SA Common Shares stock2025 Fundamental Recap & Reliable Breakout Stock Forecasts - Trung tâm Dự báo KTTV quốc gia
Should you wait for a breakout in ADC Therapeutics SAEarnings Performance Report & Accurate Buy Signal Notifications - newser.com
Is ADC Therapeutics SA showing signs of accumulationQuarterly Performance Summary & High Accuracy Swing Entry Alerts - newser.com
What insider trading reveals about ADC Therapeutics SA stockBreakout Watch & Advanced Swing Trade Entry Plans - newser.com
What is HC Wainwright's Estimate for ADCT Q1 Earnings? - MarketBeat
Key metrics from ADC Therapeutics SA’s quarterly dataCEO Change & Entry Point Confirmation Signals - newser.com
ADC Therapeutics rises on $60M PIPE financing - MSN
HC Wainwright Lowers ADC Therapeutics (NYSE:ADCT) Price Target to $7.00 - MarketBeat
What hedge fund moves indicate for ADC Therapeutics SA Common Shares stockEarnings Growth Report & Expert-Curated Trade Recommendations - newser.com
Is ADC Therapeutics SA stock attractive for long term wealth buildingStock Surge & Real-Time Market Sentiment Alerts - newser.com
Visual analytics tools that track ADC Therapeutics SA performanceJuly 2025 Big Picture & Safe Entry Point Identification - newser.com
[8-K] ADC Therapeutics SA Reports Material Event | ADCT SEC FilingForm 8-K - Stock Titan
Wealth Enhancement Advisory Services LLC Sells 3,758 Shares of ADC Therapeutics SA $ADCT - Defense World
ADC Therapeutics SA announced that it expects to receive $60.02 million in funding - MarketScreener
ADC Therapeutics (NYSE:ADCT) Sets New 52-Week HighHere's Why - MarketBeat
ADC Therapeutics raises $60 million in private placement financing - Investing.com
ADC Therapeutics raises $60 million in private placement financing By Investing.com - Investing.com Canada
ADC Therapeutics Announces $60 Million Private Placement - PR Newswire
Published on: 2025-10-13 01:51:42 - newser.com
Published on: 2025-10-12 23:16:07 - newser.com
Using flow based indicators on ADC Therapeutics SAJuly 2025 Technicals & Fast Exit Strategy with Risk Control - newser.com
What technical models suggest about ADC Therapeutics SA’s comeback2025 Short Interest & Fast Gaining Stock Reports - newser.com
Risk adjusted return profile for ADC Therapeutics SA analyzedJuly 2025 EndofMonth & Verified Technical Signals - newser.com
Weiss Ratings Reiterates “Sell (D-)” Rating for ADC Therapeutics (NYSE:ADCT) - Defense World
Using R and stats models for ADC Therapeutics SA forecastingMarket Growth Summary & Safe Capital Investment Plans - newser.com
ADC Therapeutics SA stock daily chart insightsJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com
ADC Therapeutics (NYSE:ADCT) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
ADC Therapeutics SA (NYSE:ADCT) Receives $7.75 Consensus PT from Brokerages - Defense World
ADC Therapeutics SA Hits New 52-Week High of $4.67 - Markets Mojo
ADC Therapeutics SA (NYSE:ADCT) Stock Catapults 25% Though Its Price And Business Still Lag The Industry - 富途牛牛
ADC Therapeutics Gains Ground Ahead Of LOTIS-7 Expansion, LOTIS-5 Readout - RTTNews
ADC Therapeutics targets $600M–$1B peak revenue potential for ZYNLONTA amid strategic refocus and cost cuts - MSN
Analysts Offer Predictions for ADCT Q3 Earnings - Defense World
ADC Therapeutics SA Hits New 52-Week High of USD 4.31 - Markets Mojo
Order flow analysis tools used on ADC Therapeutics SAEntry Point & Low Drawdown Trading Strategies - newser.com
Understanding ADC Therapeutics SA’s price movementTrade Risk Assessment & Daily Technical Forecast Reports - newser.com
Analyzing recovery setups for ADC Therapeutics SA investorsMarket Risk Summary & Stepwise Trade Execution Plans - newser.com
Why analysts maintain buy rating on ADC Therapeutics SA Common Shares stock2025 Market Overview & Daily Risk Controlled Trade Plans - newser.com
ADC Therapeutics SA (NYSE:ADCT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):